Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.84NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.76ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.76NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.301ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.301ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.301ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.301NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.269ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.269ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.269ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.269NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.234ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.234ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.234ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.234NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Z.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Z.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Z.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Z.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
V.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
V.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
V.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
V.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.282ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.282ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.282ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.282NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.131ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.131ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.131ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.131NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.274ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.274ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.274ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.274NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.235ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used